Rocket Pharmaceuticals (RCKT) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Rocket Pharmaceuticals (RCKT) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Rocket Pharmaceuticals

· RCKT

Dashboard

Financials

Ratios

Valuation

Statistics

284.316 M

+1.54%

General

Market Cap: $284.32M
Enterprise Value: $87.47M
Shares Outstanding: 109,190,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -4.08%
ROE: -5.76%
ROIC: -48.55%
Current Ratio: 9.24
Debt-to-Equity: 0.07
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 0.78
EV/EBITDA: 11.00

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $189.5M
Operating Income: -$191.64M
Net Profit: -$17.25M

Balance Sheet

Cash and Equivalents: $224.51M
Working Capital: $258.23M
Total Assets: $423.1M
Net Debt: -$199.71M
Total Liabilities: $54.27M
Total Equity: $368.83M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$170.28M
Cash Flow from Investing: $361.85M
Cash Flow from Financing: $90K
Free Cash Flow: -$170.4M
Capital Expenditures: $127K